NCT03750669 2025-05-13
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 3 Completed
Clinical Trials
43 trialsNCT05289908 2025-05-04
Intrathecal Pemetrexed for Leptomeningeal Metastasis
The First Hospital of Jilin University
Phase 1/2 Completed
NCT02578680 2024-09-20
MK-3475-189
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03950674 2024-06-10
MK-3475-189
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00002650 2023-06-22
High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT01328171 2023-06-15
VOLFI
AIO-Studien-gGmbH
Phase 2 Completed
NCT05625308 2022-12-22
Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions
Lo.Li.Pharma s.r.l
Phase NA Completed
NCT00998946 2021-11-05
Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Spectrum Pharmaceuticals, Inc
Phase 2 Completed
NCT00606502 2021-03-05
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Spectrum Pharmaceuticals, Inc
Phase 2 Completed
NCT04645745 2021-01-14
Myo-inositol, Alpha-Lactalbumin and Folic Acid Treatment in PCOS
AGUNCO Obstetrics and Gynecology Centre
Phase NA Completed
NCT01555190 2020-07-24
Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone
Catholic University of the Sacred Heart
Phase NA Completed
NCT00272324 2020-03-13
Aspirin/Folate Prevention of Large Bowel Polyps
Dartmouth-Hitchcock Medical Center
Phase 2/3 Completed
NCT02302326 2020-02-26
PI12/1984
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Phase NA Completed
NCT01118624 2020-01-07
Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer
Acrotech Biopharma Inc.
Phase 2 Completed
NCT00554827 2020-01-03
Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc.
Phase 1 Completed
NCT01134341 2019-12-18
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc.
Phase 1 Completed
NCT00722553 2019-12-17
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
Acrotech Biopharma Inc.
Phase 2 Completed
NCT02106650 2019-11-20
Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies
Acrotech Biopharma Inc.
Phase 2 Completed
NCT03349333 2019-10-01
A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT01165021 2019-09-25
A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer
Eli Lilly and Company
Phase 2 Completed
NCT03903952 2019-04-05
Can B12 and Folate Levels Predict HPV Penetration in Patients With ASCUS?
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Phase NA Completed
NCT01999738 2019-02-07
Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors
Endocyte
Phase 1 Completed
NCT03011320 2019-02-07
An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery
Endocyte
Phase 1 Completed
NCT03306745 2018-09-06
Micronutrient Supplementation in PCO-syndrome
Medical University of Vienna
Phase NA Completed
NCT03422289 2018-02-06
Improved Effects of MI Plus Alpha-LA in PCOS
Lo.Li.Pharma s.r.l
Phase NA Completed
NCT01188876 2018-01-19
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
Massachusetts General Hospital
Phase 1/2 Completed
NCT02013362 2017-11-09
Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Mundipharma K.K.
Phase 1/2 Completed
NCT00932113 2017-08-31
MOA
Tufts Medical Center
Phase 4 Completed
NCT00227019 2017-03-06
Phase 2 Trial of Bevacizumab in Combination With Pemetrexed
Stanford University
Phase 2 Completed
NCT00806819 2017-02-02
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
Boehringer Ingelheim
Phase 3 Completed
NCT02651636 2016-01-11
Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women
Catholic University of the Sacred Heart
Phase NA Completed
NCT01183065 2015-11-20
Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00703196 2015-10-08
Folic Acid Clinical Trial for the Prevention of Cervical Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT00973609 2015-09-01
Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)
AIO-Studien-gGmbH
Phase 3 Completed
NCT02385396 2015-03-12
Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment
Medical University of Lublin
Phase 2 Completed
NCT00096330 2014-01-13
Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT01057589 2013-09-18
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Eli Lilly and Company
Phase 2 Completed
NCT01540747 2012-02-29
Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian Syndrome
AGUNCO Obstetrics and Gynecology Centre
Phase 4 Completed
NCT01115140 2011-05-24
Metformin and Folate in Pregnant Polycystic Ovary Syndrome(PCOS) Women
University Magna Graecia
Phase 4 Completed
NCT00953355 2010-11-03
Metformin and Folate Supplementation in Polycystic Ovary Syndrome (PCOS) Patients
University Magna Graecia
Phase 4 Completed
NCT00611000 2009-02-17
Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia
National Cancer Institute (NCI)
Phase 1 Completed
NCT00018551 2009-01-21
Chemoprevention With Folic Acid
VA Office of Research and Development
Phase 2 Completed
NCT00034463 2006-07-19
ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer
Eli Lilly and Company
Phase 1 Completed